The Cetuximab Market is a monoclonal antibody used in the treatment of cancer. It is primarily used to treat colorectal cancer and head and neck cancer. Cetuximab works by inhibiting epidermal growth factor receptor (EGFR), which is a protein that promotes the growth and division of cancer cells. This drug is typically administered intravenously and is often used in combination with...